The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Embla Medical hf (Embla), formerly Ossur hf, is an orthopedic device company. It mainly focuses on prosthetics, neuro orthotics, bracing and supports, and patient care services. The company's major products include ankle and foot supports; neck and spine support products; ; walkers, knee braces; bandages; and lower limb prosthetics, including liners, knees, and feet. It offers the products to customers through the brands Ossur, Fior and Gentz, College Park, and ForMotion. The company distributes its products through a network of Orthotic and Prosthetic clinics and healthcare providers. It has manufacturing facilities in the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Embla is headquartered in Reykjavik, Iceland.Embla Medical hf Key Recent Developments
- Mar 05, 2026: Embla Medical hf: Candidates to the Board of Directors
- Feb 03, 2026: Embla Medical Releases Interim Report Q4 and Full Year 2025
- Feb 03, 2026: Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum
- Jan 09, 2026: Embla Medical hf: Conference Call Details for Q4/FY 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thuasne Cr SRO
- The Ohio Willow Wood Co
- Ottobock SE & Co KGaA
- Modern Dental Group Ltd
- Medacta Group SA
- DJO Global Inc
- Cochlear Ltd
- Breg Inc
- Bauerfeind USA Inc

